Galecto
(NASDAQ:GLTO)
1.40
00
At close: May 17
1.55
0.1500[10.71%]
PreMarket: 9:10AM EDT
15 minutes delayed
Day High/Low- - -
52 Week High/Low1.36 - 16.41
Open / Close- / -
Float / Outstanding18.6M / 25.3M
Vol / Avg.- / 66.4K
Mkt Cap35.4M
P/E-
50d Avg. Price2.03
Div / Yield-
Payout Ratio-
EPS-0.67
Total Float18.6M

Galecto (NASDAQ:GLTO), Quotes and News Summary

Galecto (NASDAQ: GLTO)

Day High/Low- - -
52 Week High/Low1.36 - 16.41
Open / Close- / -
Float / Outstanding18.6M / 25.3M
Vol / Avg.- / 66.4K
Mkt Cap35.4M
P/E-
50d Avg. Price2.03
Div / Yield-
Payout Ratio-
EPS-0.67
Total Float18.6M
Benzinga - Apr 29, 2022, 8:58AM
Benzinga - Mar 24, 2022, 1:47PM
Benzinga - Feb 17, 2022, 5:05PM
Benzinga - Nov 4, 2021, 6:23PM
Benzinga - Nov 4, 2021, 5:23PM
Benzinga - Aug 5, 2021, 8:52AM
load more
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.670
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Galecto Questions & Answers

Q
How do I buy Galecto (GLTO) stock?
A

You can purchase shares of Galecto (NASDAQ: GLTO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Galecto's (GLTO) competitors?
A

There are no as such competitors for Galecto.

Q
What is the target price for Galecto (GLTO) stock?
A

The latest price target for Galecto (NASDAQ: GLTO) was reported by Credit Suisse on Friday, August 6, 2021. The analyst firm set a price target for 7.00 expecting GLTO to rise to within 12 months (a possible 400.00% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Galecto (GLTO)?
A

The stock price for Galecto (NASDAQ: GLTO) is $1.4 last updated May 17, 2022, 7:59 PM UTC.

Q
Does Galecto (GLTO) pay a dividend?
A

There are no upcoming dividends for Galecto.

Q
When is Galecto (NASDAQ:GLTO) reporting earnings?
A

Galecto’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Galecto (GLTO) going to split?
A

There is no upcoming split for Galecto.

Q
What sector and industry does Galecto (GLTO) operate in?
A

Galecto is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.